{
    "code": "01050171",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01050171",
    "time": "2016-11-18 15:36:19",
    "許可證字號": "衛署藥製字第050171號",
    "註銷狀態": "已註銷",
    "註銷日期": "103\/12\/12",
    "註銷理由": "自請註銷",
    "有效日期": "103\/06\/05",
    "發證日期": "98\/06\/05",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00105017107",
    "中文品名": "溫血醣膜衣錠",
    "英文品名": "Winsepal Film-Coated Tablets",
    "適應症": "單一療法與Sulfonylurea、Metformin類口服降血糖劑、胰島素合併使用以控制第二型糖尿病人的血糖。",
    "劑型": "116膜衣錠",
    "包裝": "2~1000錠鋁箔盒裝 2~1000錠塑膠瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "ROSIGLITAZONEMALEATE"
    ],
    "限制項目": "01國　產 1D須執行風險管理計畫 24監視期滿學名藥 61完成BE試驗 81依100年07月27日署授食字第1001403661公告含Rosiglitazone藥品須執行風險評估暨管控計畫",
    "申請商名稱": "1217820200  溫士頓醫藥股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "1217820200  溫士頓醫藥股份有限公司",
        "製造廠廠址": "台南市永康區鹽洲里仁愛街117號",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6820400810",
            "成分名稱": "ROSIGLITAZONE MALEATE",
            "含量描述": "(Equivalent to Rosiglitazone 4mg)",
            "含量": "5.3000000000",
            "單位": "MG"
        }
    ]
}